Leadership
Tonix is led by an executive team with significant industry experience in drug development. The expertise and relationships of our passionate leadership team make Tonix Pharmaceuticals’ mission possible through proprietary developments and strategic collaborations with world-class academic and non-profit research organizations.
Executive Team
Seth Lederman, M.D.
Co-Founder, CEO & Chairman
Gregory Sullivan, M.D.
Chief Medical Officer
Bradley Saenger, CPA
Chief Financial Officer
Jessica Edgar Morris
Chief Operating Officer
Sina Bavari, Ph.D.
Executive Vice President, Infectious Disease Research and Development
Bruce Daugherty, Ph.D., MBA
Executive Vice President, Research
Siobhan Fogarty, B.Sc., M.Sc.(QP)
Executive Vice President, Product Development
Herbert Harris, M.D., Ph.D.
Executive Vice President, Translational Medicine
James Hunter, MBA
Executive Vice President, Commercial Operations
Darryl Rideout, Ph.D.
Executive Vice President, Experimental Chemistry
Zeil Rosenberg, M.D., M.P.H.
Executive Vice President, Medical
Seth Lederman, M.D.
Co-Founder, CEO & Chairman
Gregory Sullivan, M.D.
Chief Medical Officer
Bradley Saenger, CPA
Chief Financial Officer
Jessica Edgar Morris
Chief Operating Officer
Sina Bavari, Ph.D.
Executive Vice President, Infectious Disease Research and Development
Bruce Daugherty, Ph.D., MBA
Executive Vice President, Research
Siobhan Fogarty, B.Sc., M.Sc.(QP)
Executive Vice President, Product Development
Herbert Harris, M.D., Ph.D.
Executive Vice President, Translational Medicine
Darryl Rideout, Ph.D.
Executive Vice President, Experimental Chemistry
Zeil Rosenberg, M.D., M.P.H.
Executive Vice President, Medical
Board of Directors
Seth Lederman, M.D.
Co-Founder, CEO & Chairman
Richard H. Bagger
Director
Margaret Smith Bell
Director
Major General David Grange (ret)
Director
Adeoye Olukotun, M.D.
Director
R. Newcomb Stillwell
Director
Carolyn E. Taylor
Director
James Treco
Director